你好,请登录   免费注册    |    收藏本站
联系电话: 0574-87917803
联系电话: call_new 0574-87917803
NCI-H1155 [H1155]
NCI-H1155 [H1155]
规格:
货期:
编号:TS211362
品牌:Testobio
产品名称: NCI-H1155 H1155
商品货号: TS211362
Organism: Homo sapiens, human
Tissue: lung; derived from metastatic site: lymph node
Product Format: frozen
Morphology: epithelial
Culture Properties: clusters in suspension
Biosafety Level: 1

Biosafety classification is based on U.S. Public Health Service Guidelines, it is the responsibility of the customer to ensure that their facilities comply with biosafety regulations for their own country.

Disease: carcinoma; non-small cell lung cancer
Age: 36 years
Gender: male
Ethnicity: Caucasian
Derivation:
This line was derived by A.F. Gazdar, H.K. Oie, J.D. Minna and associates from a lymph node metastasis obtained from a patient prior to therapy.
Clinical Data:
36 years
Caucasian
male

Genes Expressed:
neuromedin B (NMB)
Cellular Products:
neuromedin B (NMB)
Comments:
The cells are able to synthesize the peptide NMB at 0.2 pmol/mg protein, but not the gastrin releasing peptide (GRP).
Complete Growth Medium: The base medium for this cell line is RPMI-1640 Medium (ATCC 30-2001).To make the complete growth medium, add the following components to the base medium: Fetal Bovine Serum (FBS; ATCC 30-2020) to a final concentration of 5%.
Subculturing:

Cultures can be maintained by addition of fresh medium or replacement of medium. Alternatively, cultures can be established by centrifugation of the suspension with subsequent resuspension in fresh medium. Add medium as the cell density increases.

Medium Renewal: Every 2 to 3 days

Cryopreservation:
Culture medium, 95%; DMSO, 5%
Culture Conditions:
Temperature: 37°C
STR Profile:
Amelogenin: X
CSF1PO: 12
D13S317: 14
D16S539: 9
D5S818: 10
D7S820: 8
THO1: 6
TPOX: 8
vWA: 15
Name of Depositor: AF Gazdar, JD Minna
Deposited As: Homo sapiens
References:

Giaccone G, et al. Neuromedin B is present in lung cancer cell lines. Cancer Res. 52: 2732s-2736s, 1992. PubMed: 1563005

NCI-Navy Medical Oncology Branch Cell Line Supplement. J. Cell. Biochem. suppl. 24: 1996.

首页 > 产品中心 > 微生物培养 > 菌株 > null > NCI-H1155 [H1155]

NCI-H1155 [H1155]

  • 货号: TS211362
  • 好评
询价
  • 品牌 : TESTOBIO
产品名称: NCI-H1155 H1155
商品货号: TS211362
Organism: Homo sapiens, human
Tissue: lung; derived from metastatic site: lymph node
Product Format: frozen
Morphology: epithelial
Culture Properties: clusters in suspension
Biosafety Level: 1

Biosafety classification is based on U.S. Public Health Service Guidelines, it is the responsibility of the customer to ensure that their facilities comply with biosafety regulations for their own country.

Disease: carcinoma; non-small cell lung cancer
Age: 36 years
Gender: male
Ethnicity: Caucasian
Derivation:
This line was derived by A.F. Gazdar, H.K. Oie, J.D. Minna and associates from a lymph node metastasis obtained from a patient prior to therapy.
Clinical Data:
36 years
Caucasian
male

Genes Expressed:
neuromedin B (NMB)
Cellular Products:
neuromedin B (NMB)
Comments:
The cells are able to synthesize the peptide NMB at 0.2 pmol/mg protein, but not the gastrin releasing peptide (GRP).
Complete Growth Medium: The base medium for this cell line is RPMI-1640 Medium (ATCC 30-2001).To make the complete growth medium, add the following components to the base medium: Fetal Bovine Serum (FBS; ATCC 30-2020) to a final concentration of 5%.
Subculturing:

Cultures can be maintained by addition of fresh medium or replacement of medium. Alternatively, cultures can be established by centrifugation of the suspension with subsequent resuspension in fresh medium. Add medium as the cell density increases.

Medium Renewal: Every 2 to 3 days

Cryopreservation:
Culture medium, 95%; DMSO, 5%
Culture Conditions:
Temperature: 37°C
STR Profile:
Amelogenin: X
CSF1PO: 12
D13S317: 14
D16S539: 9
D5S818: 10
D7S820: 8
THO1: 6
TPOX: 8
vWA: 15
Name of Depositor: AF Gazdar, JD Minna
Deposited As: Homo sapiens
References:

Giaccone G, et al. Neuromedin B is present in lung cancer cell lines. Cancer Res. 52: 2732s-2736s, 1992. PubMed: 1563005

NCI-Navy Medical Oncology Branch Cell Line Supplement. J. Cell. Biochem. suppl. 24: 1996.

合作单位: